Phenylalanine-free diet study for ICU adults with high phenylalanine
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether a phenylalanine-free diet is helpful for ICU patients with high phenylalanine levels in the blood. It aims to see if changing diet in critically ill adults can improve outcomes during their ICU stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 20 or older.
- You need ICU care and are expected to stay in the ICU for more than 48 hours.
- Your severity score (APACHE II) is 15 or higher.
- Your blood phenylalanine (PHE) level is at least 95 micromoles (uM) at the start of the study.
- You are not expected to die or have survival less than 3 days.
- You don’t have other serious illnesses (like end-stage cancer) that could limit survival within 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific mix of large neutral amino acids (LNAAs) can help adults with classical PKU by lowering phenylalanine levels in the brain. It includes an MRI and PET scan to see how the treatment affects brain activity.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
This study looks at whether checking phenylalanine levels at home more often helps people with classic PKU keep their levels in a healthy range. It may help you manage your diet and treatment more effectively.
This trial is testing a new slow-release protein substitute for people with PKU, to see if it is acceptable and well-tolerated. You would try the product for 7 days, replacing your usual substitute, to see how it fits into your routine.
This study tests a new medicine called sepiapterin to see if it can help control blood phenylalanine levels in people with PKU. The trial aims to find a safe and effective dose for different age groups.
This study tests a new home blood test (Egoo Phe) for measuring phenylalanine levels in people with PKU, as well as in healthy adults. It aims to see if it is accurate and easy to use.
Hear when a new Non-Phenylketonuric Hyperphenylalaninemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.